통합검색
내가 찾은 검색어
'sorafenib' 에 대한 통합검색결과 42건입니다.
한빛사42건
-
Multicenter Phase 2 Trial of Second-Line Regorafenib in Patients with Unresectable Hepatocellular Carcinoma after Progression on Atezolizumab plus Bev
- Liver Cancer January 21 2025 | https://doi.org/10.1159/000543666
- 2025.01
- 의약학
-
Risk of Bleeding in Hepatocellular Carcinoma Patients Treated with Atezolizumab/Bevacizumab: A Systematic Review and Meta-Analysis
- Liver Cancer Dec 2024, 13 (6) | https://doi.org/10.1159/000539423
- 2024.12
- 의약학
-
[Correspondence] Correspondence on letter to the editor regarding “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma“
- Clin. Mol. Hepatol. Oct 21 2024, | https://doi.org/10.3350/cmh.2024.0916
- 2024.10
- 의약학
-
[Correspondence] Correspondence to editorial on “Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure
- Clin. Mol. Hepatol. Volume 30(4); Oct 2024 | https://doi.org/10.3350/cmh.2024.0394
- 2024.10
- 의약학
-
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries
- Liver Cancer August 20 2024 | https://doi.org/10.1159/000540969
- 2024.08
- 의약학
-
Efficacy and safety of bintrafusp alfa in two phase 1 expansion cohorts with advanced hepatocellular carcinoma
- Hepatology Aug 13 2024, | https://doi.org/10.1097/HEP.0000000000001054
- 2024.08
- 의약학
-
Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after Atezolizumab/Bevacizumab Failure: A real-world study
- Clin. Mol. Hepatol. Volume 30(3); Jul 2024 | https://doi.org/10.3350/cmh.2023.0553
- 2024.07
- 의약학
-
Genomic Biomarkers to Predict Response to Atezolizumab Plus Bevacizumab Immunotherapy in Hepatocellular Carcinoma: Insights from the IMbrave150 Trial
- Clin. Mol. Hepatol. Jul 23 2024, | https://doi.org/10.3350/cmh.2024.0333
- 2024.07
- 의약학
-
-
Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatoc
- Drug Resist. Update Available online 17 January 2024 | https://doi.org/10.1016/j.drup.2024.101054
- 2024.01
- 생명과학
-
Aneurysm and Artery Dissection After Oral VEGFR-TKI Use in Adults With Cancer
- JAMA Netw. Open Nov 01 2023, 6 (11) | https://doi.org/10.1001/jamanetworkopen.2023.45977
- 2023.11
- 의약학
-
Bentonite as a water-insoluble amorphous solid dispersion matrix for enhancing oral bioavailability of poorly water-soluble drugs.
- J. Control. Release Oct 03 2023, S0168-3659(23)00650-8 | https://doi.org/10.1016/j.jconrel.2023.09.051
- 2023.10
- 의약학
-
Immunotherapy for hepatocellular carcinoma: Recent advances and future targets
- Pharmacol. Ther. 2023 Apr;244:108387 | https://doi.org/10.1016/j.pharmthera.2023.108387
- 2023.04
- 의약학
-
Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
- Cancer Commun. 2023 Mar 14 | https://doi.org/10.1002/cac2.12414
- 2023.03
- 의약학
-
Cancer-associated fibroblast-derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
- Cancer Commun. 2023 Mar 14 | https://doi.org/10.1002/cac2.12414
- 2023.03
- 의약학
-
은정우
아주대학교 의과대학
- Cancer Commun.
- 2023.03.27
-
Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study
- Eur. J. Cancer Volume 175, November 2022, Pages 204-213 | https://doi.org/10.1016/j.ejca.2022.08.024
- 2022.11
- 의약학
-
이성환
차의과학대학교 분당차병원
- Hepatology
- 2022.04.18
-
Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma
- J. Exp. Clin. Cancer Res. Published 14 March 2022 | https://doi.org/10.1186/s13046-022-02296-3
- 2022.03
- 의약학
-
Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes
- Hepatology First published: 29 March 2022 | https://doi.org/10.1002/hep.32490
- 2022.03
- 의약학
